As the second largest economy in the Western Hemisphere, Brazil is an attractive destination for U.S. exporters of innovative products and services. From the commercial perspective, Brazil spends 9.2% of GDP in healthcare, with public and private investments. Areas of opportunity for U.S. healthcare and healthcare IT are trending toward telemedicine, EMR, interoperability systems, imaging diagnostics, implants, in vitro diagnostics, biotechnology, pharmaceuticals and supplements. Recent regulatory improvements, such as some revisions in Anvisa regulations, to reduce bureaucracy and registration timeframe of medical equipment and pharmaceuticals are another reason to look again at Brazil.
Brazil’s Ministries of Science, Technology, Innovations and Communications(MCTCIC) and Health launched the Chamber of Health 4.0., with the mission of transforming the technology and innovation in the health system, to accelerate the fight against diseases and patient diagnoses, and in the reorganization of the data system of public and private hospitals. The project will have a period of one year to present new projects and could cost between US$ 1 billion and US$ 1.5 billion.
-
Brazil is the second largest economy in the Western Hemisphere.
-
Brazil offers excellent opportunities for U.S. healthcare companies, especially in the Healthcare IT, Medical Devices and Nutritional supplement industries.
-
A favorable business climate, regulatory improvements, and strong trade and investment support programs make the Brazilian healthcare sector an attractive proposition in the region.
-
Of the approximately 6,500 hospitals, 70% are private. There are approximately 495,000 hospital beds, 96,000 healthcare supplementary services, 432,000 physicians, 144,000 dentists, and 70,000 drugstores.
-
Brazil ranks among the top six markets in size for drugs and pharmaceuticals, with sales of US$ 28.4 billion in 2018.
-
In 2018, Brazil increased imports by 9.7% in medicines and raw materials reaching U$7.2 billion.
-
In 2018, Brazil increased imports of medical devices by 21.8%, reaching U$5.4 billion.
